Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 1 7Phase NA 3Phase 1/2 2Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Graft vs Host Disease 4Myeloproliferative Disorders 3Myasthenia Gravis 3Lymphoma, Non-Hodgkin 3Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Anemia, Refractory, with Excess of Blasts 2Skin Neoplasms 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Myeloproliferative Syndrome, Transient 1Multiple Myeloma 1Leukemia 1Congenital Abnormalities 1Chromosome 5q Deletion Syndrome 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1

Interventions

ruxolitinib 6Early Intervention, Educational 3parsaclisib 2navitoclax 2liposomal amphotericin B 2fedratinib 2Psychiatric Rehabilitation 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Cyclophosphamide 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2selinexor 1pomalidomide 1peginterferon alfa-2b 1peginterferon alfa-2a 1luspatercept 1imetelstat 1fludarabine 1bomedemstat 1Whole-Body Irradiation 1Valacyclovir 1Therapeutics 1Tacrolimus 1Ribavirin 1Radiotherapy 1Pharmacogenomic Testing 1Palivizumab 1Ondansetron 1N(4)-oleylcytosine arabinoside 1Moxifloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Primary Myelofibrosis × Tacrolimus × Clear all
NCT03480360 2026-02-19

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Dartmouth-Hitchcock Medical Center

Phase 3 Active not recruiting
21 enrolled 19 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Lymphoma, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Neoplasms, Plasma Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡